SCHEMBL23974073

SCHEMBL23974073

C[C@@H](CCCCNC(=O)CC[C@H](C)C(=O)O)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ ITGB3 P05106 1/20 0.40
▸ ITGA2B P08514 1/20 0.40
▸ GABRR1 P24046 2/20 0.39
▸ CASP2 P42575 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ ALB P02768 3/20 0.38
▸ LMNA P02545 2/20 0.37
▸ ACE2 Q9BYF1 1/20 0.37
▸ NAAA Q02083 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NOD1 Q9Y239 1/20 0.36
▸ TBXAS1 P24557 1/20 0.35
▸ FOLH1 Q04609 1/20 0.35
▸ PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16638262 0.86 ALDH1A1 (0.44) LTA4HALDH1A1CYP1A2ITGB3ITGA2B
SCHEMBL12891254 0.83 EPHX2 (0.51) ALDH1A1ITGB3ITGA2BCASP2LMNA
SCHEMBL19438356 0.83 CASP2 (0.61) CASP2NAAA
SCHEMBL20873621 0.83 CASP2 (0.61) CASP2NAAA
SCHEMBL19069567 0.82 CASP2 (0.59) LTA4HALDH1A1CYP1A2CASP2BLM
SCHEMBL12413859 0.82 CYP1A2 (0.52) LTA4HALDH1A1CYP1A2GABRR1CASP2
SCHEMBL20055001 0.80 CASP2 (0.52) ALDH1A1CYP1A2CASP2ACE2NAAA
SCHEMBL25878486 0.80 CASP2 (0.57) CASP2NAAAMEN1KMT2ANOD1
SCHEMBL13120985 0.80 CASP2 (0.57) CASP2NAAAMEN1KMT2ANOD1
SCHEMBL20038715 0.80 LTA4H (0.50) LTA4HCYP1A2ITGB3ITGA2BGABRR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3903825-A1 BI-LIGAND DRUG CONJUGATE AND USE THEREOF Coherent Biopharma (Suzhou), Limited (CN) 2021-11-03 — — EP disclosed
Send feedback